Literature DB >> 25921663

Classification and staging of hepatocellular carcinoma: an aid to clinical decision-making.

Benyam D Addissie1, Lewis R Roberts2.   

Abstract

Classification and staging of hepatocellular carcinoma in a way that allows optimal treatment selection is challenging. This article summarizes some of the classification and staging schemes and discusses the conceptual framework that guides optimal treatment selection for each patient. The article does not exhaustively discuss each staging system proposed in the last three decades, but rather reviews the most commonly used staging systems, evaluates the rationale behind some of the newer staging systems, and compares them focusing on their use in clinical decision-making, notably choice of therapy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classification; Hepatocellular carcinoma; Treatment selection; Tumor staging

Mesh:

Substances:

Year:  2015        PMID: 25921663     DOI: 10.1016/j.cld.2015.01.011

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  11 in total

1.  Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection.

Authors:  Bin Yu; Han Liang; Qifa Ye; Yanfeng Wang
Journal:  J Gastrointest Surg       Date:  2020-03-03       Impact factor: 3.452

2.  Does microvascular invasion in Barcelona Clinic Liver Cancer stage A multinodular hepatocellular carcinoma indicate early-stage behavior?

Authors:  Han Wang; Long-Hai Feng; You-Wen Qian; Zhen-Ying Cao; Meng-Chao Wu; Wen-Ming Cong
Journal:  Ann Transl Med       Date:  2019-09

3.  A Powerful Nomogram Based on the Novel D-Index to Predict Prognosis After Surgical Resection of Hepatocellular Carcinoma.

Authors:  Xia Du; Cheng-Nan Guo; Xiao-Dong Bao
Journal:  Cancer Manag Res       Date:  2021-03-17       Impact factor: 3.989

4.  Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide-Treated Human Hepatocellular Carcinoma Cell Line HepG2.

Authors:  Yuan Luo; Xinyu Wen; Ling Wang; Jing Gao; Zi Wang; Chunyan Zhang; Pengjun Zhang; Chengrong Lu; Lianning Duan; Yaping Tian
Journal:  Oxid Med Cell Longev       Date:  2016-08-15       Impact factor: 6.543

Review 5.  Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial Chemoembolization.

Authors:  Patrick Vande Lune; Ahmed K Abdel Aal; Sergio Klimkowski; Jessica G Zarzour; Andrew J Gunn
Journal:  J Clin Transl Hepatol       Date:  2018-01-05

Review 6.  Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma.

Authors:  Xue-Qin Li; Xing Wang; Da-Wei Zhao; Jun Sun; Jiao-Jiao Liu; Dong-Dong Lin; Guang Yang; Hui Liu; Zhen-Ying Xia; Cui-Yu Jia; Hong-Jun Li
Journal:  World J Surg Oncol       Date:  2020-08-22       Impact factor: 2.754

7.  Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.

Authors:  Keshu Hu; Jia Yuan; Bei Tang; Feng Zhang; Shenxin Lu; Rongxin Chen; Lan Zhang; Zhenggang Ren; Xin Yin
Journal:  Ann Transl Med       Date:  2021-02

8.  Clinical guideline SEOM: hepatocellular carcinoma.

Authors:  J Sastre; R Díaz-Beveridge; J García-Foncillas; R Guardeño; C López; R Pazo; N Rodriguez-Salas; M Salgado; A Salud; J Feliu
Journal:  Clin Transl Oncol       Date:  2015-11-25       Impact factor: 3.405

9.  A sample model established by S-index predicting overall survival after curative resection of primary hepatocellular carcinoma.

Authors:  Lei Chen; Bin-Bin Cai; Chao-Jun Zhou; Xiang-Qing Hou; Si-Pin Hu; Guan Fang; Wen-Chao Chen; Lin-Hui Li; Wen-Jun Yang
Journal:  Cancer Manag Res       Date:  2019-01-14       Impact factor: 3.989

10.  Management and survival for patients with stage-I hepatocellular carcinoma: An observational study based on SEER database.

Authors:  Zhaoping Wu; Weili Chen; Ting Ouyang; Hechun Liu; Lingling Cao
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.